Candel Therapeutics, Inc. (CADL) stock
CADLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.32−0.08 (-1.48%)
Close on Nov 18, 2026Market cap $407.08MP/E –Yield –
Candel Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Candel Therapeutics's market cap was $701.81M on Nov 11, 2026, against $261.85M a year earlier. Over the last 5 years it ranged from $26.00M to $994.87M, with a median of $181.95M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $701.81M | +126.3% |
| 2025 | Dec 31, 2025 | $310.16M | +11.2% |
| 2024 | Dec 31, 2024 | $278.85M | +555.9% |
| 2023 | Dec 29, 2023 | $42.51M | -17.8% |
| 2022 | Dec 30, 2022 | $51.72M | -76.9% |
| 2021 | Dec 31, 2021 | $224.35M | – |
See a number that looks wrong?